PharmaCell enters an agreement purchase TiGenix therapy production facility.

BASF receives EXCiPACT Certification for the group of polyvinylpyrrolidone polymers, produced in Germany.

Mayne Pharma appoints Stefan Cross as president of its US division.

Solvias appoints Karen Huebscher as its new CEO.

I Holland announces service that predicts solutions for tablet sticking problems.

Jeff Yuen had been appointed executive vice-president, global quality for combined companies.

Regis Technologies passes a recent FDA audit with no Form 483 observations.

Optima pharma GmbH appoints Stephan Reuter as its new CEO.

Eurofins MWG Operon expands its exome sequencing services with the Ion Proton Next Generation Sequencer.

AstraZeneca and Bristol-Myers Squibb Diabetes Alliance provides a $5 million grant to the American Diabetes Association.

International Society for Pharmaceutical Engineering will continue strategic plan initiated by Nancy Berg; search begins for replacement.

Teva reports FDA approval for three-times-a-week Copaxone 40 mg/mL.

Covance appoints Barry J. Goldstein as its new vice-president of Clinical Development Services and Global Therapeutic Area Head.

SGS to offer program-based stability testing services for biopharmaceuticals from Wokingham, UK facility.

EMA's guidance focuses on the use of pharmacogenomics to improve drug safety monitoring.

NCI launches trial to assess the utility of genetic sequencing to improve patient outcomes.

Novozymes Biopharma has released new study data on extending the serum half-life of albumin in vivo.

The Committee for Medicinal Products for Human Use (CHMP) held a meeting on Jan. 20-23, 2014.

Products enable testing in accordance with methods described in new USP monograph.

FDA adds Ranbaxy's Toansa, India facility to existing consent decree, prohibiting distribution of APIs from that location

Competition seeks to encourage academic research and accelerate drug delivery applications.

In 2013, the EMA's Committee for Medicinal Products for Human Use recommended 81 medicines for human use for marketing authorization, compared with 57 in 2012.

Shire appoints Susan Kilsby as its New Chairman.

Teva announced an agreement to acquire NuPathe and its migraine treatment patch.

NovePen Echo is the first insulin injection device combining half-unit dosing and memory function

J&J's diagnostics business goes to global asset manager, The Carlyle Group.

InformEx, North America's business partnering event for buyers and sellers of high-value chemistry, has launched the 30th edition of its annual conference at the Miami Beach Convention Center.

Patheon will display its late-stage API development capabilities at InformEx.